Intra-Cellular Therapies, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Intra-Cellular Therapies, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q1 2019 to Q3 2024.
  • Intra-Cellular Therapies, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending September 30, 2024 was $4.09M, a 19.3% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.09M -$976K -19.3% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $4.46M -$1.01M -18.5% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $4.29M -$1.59M -27.1% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $4.67M -$1.64M -26% Dec 31, 2023 10-K 2024-02-22
Q3 2023 $5.07M Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $5.47M Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $5.88M Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $6.31M Dec 31, 2022 10-K 2023-03-01
Q4 2019 $12M Dec 31, 2019 10-K 2020-03-02
Q3 2019 $12.5M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $13.1M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $13.6M Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.